Breaking News

Financial Report: BASi

October 18, 2013

Returns to profitability in the quarter

3Q Revenues:
$5.6 million (-22%)

3Q Earnings: $576,000 (loss of $246,000 3Q12)

YTD Revenues: $16.6 million (-24%)

YTD Earnings: $521,000 (loss of $3.6 million YTD13)

Comments: Service revenue for the quarter was down 20% to $4.2 million, impacted by the consolidation of BASi's Oregon lab into its West Lafayette facility. Product revenue decreased 27% to $1.4 million, primarily due to lower sales of Culex automated sampling systems. Earnings in the quarter are attributed to a higher gross margin and lower operating expenses. Restructuring charges impacted 2012 earnings.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks